National Centre for Clinical Research on Emerging Drugs
About
In recent decades, authors affiliated with National Centre for Clinical Research on Emerging Drugs have published 1.5k papers, which have received a total of 76.8k indexed citations.
Scholars at this organization have produced 682 papers in Epidemiology, 572 papers in Infectious Diseases and 323 papers in Virology on the topics of Prevention and Treatment of HIV/AIDS Infection (433 papers), HIV Research and Treatment (320 papers) and HIV, Drug Use, Sexual Risk (306 papers). Their work is cited by papers focused on Epidemiology (31.9k citations), Infectious Diseases (25.9k citations) and Virology (15.6k citations). Authors at National Centre for Clinical Research on Emerging Drugs collaborate with scholars in Australia, United States and United Kingdom and have published in prestigious journals including New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet. Some of National Centre for Clinical Research on Emerging Drugs's most productive authors include John Kaldor, Matthew Law, David A. Cooper, Gregory J. Dore and Andrew E. Grulich
In The Last Decade
Explore institutions with similar magnitude of impact
Top countries impacted by scholars at Shriners Hospitals for Children - Erie Top fields impacted by scholars at HUN-REN Institute of Experimental Medicine Top authors scholars at Center for Genomic Science are specifically Top fields impacted by scholars at Federal Institute of Hydrology Top countries scholars at Urho Kaleva Kekkonen Institute are collaborate with authors working in Top fields impacted by scholars at American Medical Association Top fields scholars at Canadian Institute for Theoretical Astrophysics are working on Top authors scholars at Toin University of Yokohama are specifically